Loading lessons…
Peptide learning paths
Learn peptides step by step
Curated lessons across 8 learning paths — from first concepts to trial summaries and practical protocols. Pick your level, follow the curriculum, and build real understanding.
Where are you starting?
190lessons
8paths
0day streak
0%explored
Start your first lesson
Choose a learning path below or search the library. Progress saves in your browser.
Learning paths
Pick a track — progress rings update as you complete lessons.
Guided curriculum
Peptide deep dives: compounds in context
Intermediate learners use these modules to understand specific peptides — mechanisms, evidence quality, and how they differ from lookalikes.
Who it's for: You've completed basics and want compound-level literacy before choosing a stack.
Unit 1
Module 1 — Tissue repair peptides
BPC-157, TB-500, and recovery-focused compounds.
You'll be able to
- ✓Contrast repair peptides by mechanism
- ✓Read injury-recovery evidence honestly
- ✓Plan stacks without redundant overlap
Unit 2
Module 2 — Metabolic & GH-axis peptides
GLP-1 class, secretagogues, and fat-loss adjacent compounds.
You'll be able to
- ✓Map GLP-1 mechanisms to expectations
- ✓Compare secretagogue approaches
- ✓Understand lean-mass tradeoffs
83 lessons in Peptide Deep Dives
6mPeptidesBeginner
Should You Cycle NAD+? The Complete Guide to NAD+ Protocols
Daily NAD+ supplementation can plateau due to NAMPT downregulation. Here's how to cycle NMN and NR for sustained results.
8mPeptidesIntermediate
July 2026 Peptide Research Snapshot: Retatrutide, BPC-157, MOTS-C, GHK-Cu, and Tesamorelin
The peptide space is loud. This snapshot cuts through the noise and focuses on the compounds that still have real biology behind them.
8mPeptidesIntermediate
MOTS-C and Human Mesenchymal Stromal Cells: The Tradeoff Nobody Wanted to Miss
MOTS-C may help metabolic signaling in human cells, but the same signal could come with a repair cost. That matters for anyone reading the longevity hype.
10mPeptidesIntermediate
July 2026 Peptide Research Signals: The 5 Compounds Worth Watching
The most useful peptide research is not the loudest. It is the stuff that changes the question from 'does it work?' to 'who does it help, for what outcome, and with what tradeoffs?'
9mPeptidesIntermediate
Therapeutic Peptides in Gerontology: What Healthy Aging Research Actually Shows
Healthy aging is not a slogan. It is a measurable question about inflammation, tissue repair, metabolic control, and whether a peptide has human data behind it.
9mPeptidesIntermediate
Injectable Peptides in Sports Medicine: What the Evidence and Antidoping Rules Actually Say
Sports medicine keeps pulling peptides into the conversation because recovery pressure is real. The hard part is separating promising biology from weak evidence, gray-market hype, and antidoping risk.
9mPeptidesIntermediate
What Real-World GLP-1 Data Actually Tells Us About Safety and Results
Clinical trials show the headline results. Real-world data shows what happens after the first prescription, after the side effects, and after people try to stay on therapy long enough to benefit.
8mPeptidesIntermediate
GLP-1s, Delayed Gastric Emptying, and Surgery: What the Perioperative Debate Means
GLP-1s can slow gastric emptying, which is why surgery teams now ask different questions. The key is to understand the risk without turning it into fear or hype.
9mPeptidesIntermediate
MOTS-C and Mitochondrial Repair: Why This Peptide Keeps Showing Up in Recovery Research
MOTS-C sits at the intersection of mitochondrial signaling, glucose control, and recovery biology. Here is what the current research can actually support.
9mPeptidesIntermediate
GHK-Cu, Collagen, and Tissue Remodeling: What the Research Actually Suggests
GHK-Cu is more than a cosmetic peptide. The interesting signal is tissue remodeling, matrix repair, and how that may matter for skin, hair, and recovery.
8mPeptidesIntermediate
MOTS-C and Muscle Mitochondrial Efficiency: What the New Data Means
New MOTS-C data points to something more specific than a generic metabolism story: better muscle mitochondrial efficiency. Here's what that means in practice.
9mPeptidesIntermediate
Retatrutide Is Approaching Surgery-Level Weight Loss: What the New Data Actually Means
Retatrutide's weight-loss signal is now strong enough that people are comparing it with surgery. That comparison is useful, but only if you understand what the numbers do and do not mean.
9mPeptidesIntermediate
Retatrutide and Chronic Kidney Disease: What the 2026 Meta-Analysis Adds
Retatrutide is no longer just a weight-loss story. The latest kidney-aware review sharpens the question: which metabolic patients need tighter monitoring, slower escalation, and better data?
8mPeptidesIntermediate
MOTS-c and Cardiac Ischemia-Reperfusion: What the New Rat-Heart Study Shows
MOTS-c is showing up in cardiac stress research. A new rat-heart study points toward mitochondrial bioenergetics, mtDNA integrity, and post-ischemic recovery.
8mPeptidesIntermediate
MOTS-c and Inflammatory Lung Disease: What the New Research Suggests
MOTS-c is moving beyond generic energy claims. New research points toward mitochondrial stress response, lung inflammation, and cardiac reperfusion biology.
8mPeptidesIntermediate
GLP-1s and Biological Aging: What the New Semaglutide Study Shows
GLP-1 research is moving into healthspan and epigenetic aging. The new semaglutide signal is worth tracking, but it is not proof of age reversal.
8mPeptidesIntermediate
MOTS-c and Soft Tissue Survival: What the New Autophagy Study Suggests
MOTS-c is being studied beyond energy and metabolism. New research points toward tissue-stress biology, lysosomal stability, and cell survival under ischemic pressure.
8mPeptidesIntermediate
GLP-1s and Breast Cancer Risk: What the New Signal Means
GLP-1 research is moving beyond weight loss. New breast cancer risk and survival signals are interesting, but they need careful interpretation.
8mPeptidesIntermediate
Amylin and GLP-1: The Next Wave of Metabolic Peptides
The next metabolic peptide wave is not just stronger GLP-1 dosing. Amylin, GIP, glucagon, and combination protocols are changing what serious tracking should include.
7mPeptidesIntermediate
CagriSema and Amylin: Why GLP-1 Stacks Are Changing in 2026
GLP-1 therapy is no longer just GLP-1. CagriSema, cagrilintide, petrelintide, and amycretin show why amylin is becoming a serious metabolic target.
8mPeptidesIntermediate
MOTS-c and Arterial Stiffness: What the 2026 Pilot Study Shows
A new MOTS-c pilot study adds a vascular-health signal to the mitochondrial peptide conversation, but it should be read as biomarker research, not a protocol claim.
7mPeptidesIntermediate
MOTS-c and NAD+: The Mitochondrial Longevity Pair Gaining Serious Scientific Attention
MOTS-c is a peptide encoded in your mitochondrial DNA that declines with age and mimics exercise benefits in animal studies. NAD+ has actual human clinical data. Here's what 2026 research shows about why these two molecules may work together — and what's still missing.
7mPeptidesIntermediate
Dapiglutide: What the GLP-1/GLP-2 Obesity Trial Means
Dapiglutide is not another simple GLP-1 copycat. The early 2026 trial missed statistical significance for weight loss, but the mechanism points toward the next phase of peptide design.
9mPeptidesIntermediate
Semax: The Neuroprotective Peptide Changing Cognitive Research
Semax is an ACTH-derived peptide that upregulates BDNF and supports neuroprotection. Here's what the research actually shows — and how to track your cognitive protocol.
5mPeptidesBeginner
How to Reconstitute and Dose NAD+: A Practical Guide
Learn the proper technique for reconstituting NAD+ vials, understanding concentration calculations, and building an effective dosing protocol for your research needs.
8mPeptidesIntermediate
GHK-Cu vs Minoxidil: The Copper Peptide That Outperformed the #1 Hair Loss Treatment
Most people fighting hair loss default to minoxidil. But a 2022 clinical trial showed a 0.5% GHK-Cu serum increased hair count by 22% over 16 weeks — beating 3% minoxidil. And GHK-Cu doesn't just grow hair. It works at the genomic level.
8mPeptidesIntermediate
MOTS-C Daily vs Weekly Dosing: Which Protocol Works Best?
The MOTS-C dosing debate is real: 0.5-1mg daily vs 5mg 2-3x weekly. Both protocols have their advocates. Here's what the research says, why context matters, and how to choose the right approach for your situation.
7mPeptidesIntermediate
FDA Removes GHK-Cu from Category 2: What Peptide Users Need to Know
On April 15, 2026, the FDA announced it will remove injectable GHK-Cu from Category 2 — the list that blocked compounding pharmacies from producing it. This is a major regulatory shift for one of the most studied copper peptides in longevity research.
7mPeptidesIntermediate
Why Peptide Therapy Is Going Mainstream in 2026
Peptide therapy searches on TikTok jumped 459% in early 2026. Here's what's driving the explosion, which peptides are trending, and what you need to know before you start.
9mPeptidesIntermediate
Retatrutide Cuts Knee Pain by 75.8%: What the TRIUMPH-4 Trial Means Beyond Weight Loss
Everyone focused on the 71-pound weight loss stat from TRIUMPH-4. But the buried finding — 75.8% reduction in knee pain scores — may be the more important number for anyone living with joint pain.
9mPeptidesIntermediate
MOTS-C and NAD+: Do They Work Together? (Complete Stacking Guide)
MOTS-C activates AMPK through mitochondrial signaling. NAD+ feeds the cellular energy substrate. Together, they hit the same system from two different angles — and the results are additive.
10mPeptidesIntermediate
MOTS-C Long-Term Use: Does Your Body Stop Responding?
MOTS-C activates AMPK and drives mitochondrial adaptation — but does daily use over months cause your body to stop responding? Here's what the research and user experience actually says about long-term MOTS-C protocols.
9mPeptidesIntermediate
GHK-Cu and Cognitive Aging: New Research on the Copper Peptide's Brain Benefits
GHK-Cu has long been known for its skin and healing benefits. A fresh April 2026 preprint adds a surprising new dimension — cognitive aging reversal in mouse models via BDNF upregulation and neuroinflammation suppression.
9mPeptidesIntermediate
Epitalon: The Telomere Peptide That Actually Has Research Behind It
Epitalon is a synthetic tetrapeptide developed from pineal gland extract that activates telomerase and has decades of Khavinson research behind it. Here's what it does, how to dose it, and how to stack it.
8mPeptidesIntermediate
Should You Cycle NAD+? The Complete Guide to NAD+ Protocols
Most people who take NAD+ daily wonder whether they should cycle it. The answer isn't black and white — it depends on your dose, delivery method, and goals. Here's what the research and community experience actually suggest.
8mPeptidesIntermediate
Epithalon (Epitalon): The Longevity Peptide That May Extend Your Telomeres
Epithalon is one of the most researched longevity peptides in existence, with decades of clinical data behind it. This guide covers the science of telomere elongation, dosing options, cycling protocols, and how it fits into a modern anti-aging stack.
8mPeptidesIntermediate
BRP Peptide: Stanford's AI-Discovered 'Natural Ozempic' Explained
A Stanford AI tool screened 2,600 uncharacterized peptides and identified BRP — a 12-amino acid molecule that cuts food intake by up to 50%, promotes fat burning, and avoids the nausea, constipation, and muscle loss common with GLP-1 drugs. Here's what the research actually shows.
9mPeptidesIntermediate
Tesamorelin: The Science-Backed Growth Hormone Peptide for Fat Loss and Longevity
Tesamorelin is an FDA-approved GHRH analog with clinical trials proving 15–20% visceral fat reduction. Here's the full science, dosing guide, and what the latest research reveals about its longevity applications.
10mPeptidesIntermediate
GHK-Cu Regulates Over 4,000 Human Genes: The Epigenetic Science Explained
Most people know GHK-Cu for skin and wound healing. What they don't know: it's one of the most potent epigenetic regulators ever studied, influencing over 4,000 human genes — many tied directly to aging, inflammation, and tissue repair.
7mPeptidesIntermediate
MOTS-C Dosing Guide: Recommended Dose and How to Take It
MOTS-C is one of the most studied mitochondrial peptides for metabolic health and longevity. This guide covers dosing ranges, frequency, timing, stacking options, and what to track on protocol.
9mPeptidesIntermediate
MOTS-c Enters Phase 2a Human Trial for Prediabetes: What the Research Shows
MOTS-c — a peptide synthesized inside your own mitochondria — is now in Phase 2a human trials for prediabetes. Early data suggests it improves insulin sensitivity and metabolic flexibility without the side effects of pharmaceutical interventions.
10mPeptidesIntermediate
Retatrutide Phase 3 Results: 28.7% Body Weight Reduction Sets a New Standard
Phase 3 trial data is in: retatrutide delivers 28.7% average body weight reduction, outpacing every approved GLP-1 therapy. The numbers tell a clear story about where metabolic medicine is heading.
8mPeptidesIntermediate
SS-31 and MOTS-C: The Mitochondrial Stack Guide
SS-31 and MOTS-C target mitochondrial health from two different angles. Here's how to run them together, when to introduce each, and what to expect.
9mPeptidesIntermediate
GHK-Cu: The Copper Peptide Accelerating Wound Healing and Skin Regeneration
A 2026 Phase 2 clinical trial confirms GHK-Cu achieves 25% faster wound closure and tissue regeneration versus control. Discover how this naturally occurring copper peptide triggers stem cell activity, collagen synthesis, and anti-inflammatory cascades.
9mPeptidesIntermediate
MOTS-c: The Mitochondrial Peptide Rewriting Longevity Science
Discovered inside mitochondrial DNA itself, MOTS-c is one of the most fascinating longevity peptides in modern science. It governs how your cells produce energy, fight fat accumulation, and age.
9mPeptidesIntermediate
Ipamorelin and CJC-1295: The Complete Growth Hormone Peptide Stack Guide
Two peptides, one powerful GH pulse. Ipamorelin and CJC-1295 work together to mimic natural growth hormone release — here's the complete guide on why, how, and when to stack them.
8mPeptidesIntermediate
NAD+ and Peptide Stacking: How to Combine Them for Recovery and Longevity
NAD+ and peptides like BPC-157, MOTS-C, and KLOW work through completely different pathways — which is exactly why they stack well. Here's how to combine them safely and effectively.
10mPeptidesIntermediate
36 Studies Confirm BPC-157 Heals Musculoskeletal Tissue: What the New Systematic Review Found
The largest systematic review of BPC-157 to date analyzed 36 studies and confirmed consistent healing outcomes across tendons, ligaments, bone, and muscle tissue. Here's what the data shows.
8mPeptidesIntermediate
MOTS-C vs GHK-Cu for Muscle Building Over 50: Which Peptide Should You Choose?
Both MOTS-C and GHK-Cu are popular among serious lifters over 50 — but they work through completely different mechanisms. Here's how to choose, and why the best answer is often both.
11mPeptidesIntermediate
Why Retatrutide is Winning: Clinical Data Shows 28% Superior Fat Loss Over GLP-1
A 2026 meta-analysis comparing retatrutide to GLP-1 (Ozempic/Wegovy) and tirzepatide shows retatrutide delivers 28% superior fat loss. Here's the science behind why the triple-agonist approach is reshaping weight loss and body recomposition.
7mPeptidesIntermediate
GHK-Cu Dosing Guide: How to Use Copper Peptide for Skin, Healing, and Longevity
GHK-Cu is one of the most researched anti-aging peptides available. Here's a practical dosing guide covering protocols, cycle length, stacking, and what to realistically expect.
10mPeptidesIntermediate
TB-500 and Cardiac Recovery: What the 2026 Human Trial Data Shows
TB-500 has moved from rodent models to human cardiac recovery trials. The 2026 data is early, but the mechanism and results are worth understanding — especially if you're using TB-500 for recovery.
11mPeptidesIntermediate
BPC-157: The Peptide That Regenerates Tissue—Science, Clinical Evidence, and Real Results
BPC-157 activates multiple tissue repair pathways simultaneously. Users report faster recovery from injury, improved gut healing, enhanced joint mobility—backed by published clinical data.
9mPeptidesIntermediate
BPC-157 and Wound Healing: The Science Behind the 'Body Protection Compound'
BPC-157 accelerates tissue repair by stimulating angiogenesis and collagen synthesis. Here's what the research shows and what users need to know.
9mPeptidesIntermediate
MOTS-C: The Mitochondrial Peptide That Boosts Metabolism and Exercise Performance
MOTS-C is the first peptide found encoded in mitochondrial DNA. It activates AMPK, mimics exercise-induced metabolic adaptations, and may be one of the most powerful tools for metabolic optimization available.
10mPeptidesIntermediate
The Science of Retatrutide: How GLP-1/GIP/Glucagon Triple Agonists Work
Retatrutide's triple receptor mechanism simultaneously suppresses appetite, enhances metabolic function, and activates thermogenesis. Here's the science behind why it delivers 24% body weight reduction.
14mPeptidesAdvanced
Peptides for Longevity: The Emerging Science Behind Age-Reversal Compounds
The peptide space is shifting from weight loss toward longevity. Explore the science behind peptides designed to slow aging, repair cellular damage, and extend healthspan.
10mPeptidesIntermediate
Latest Peptide Research Breakthroughs: What's Coming in 2026
The peptide space is evolving rapidly. Here's what researchers are discovering, which new compounds show promise, and what breakthroughs could hit the market soon.
10mPeptidesIntermediate
How Retatrutide Works: The Science Behind the Triple-Receptor Agonist
Retatrutide is not just a stronger tirzepatide. It's a fundamentally different molecule with three receptor targets instead of two. Here's how each mechanism contributes to rapid fat loss, metabolic optimization, and muscle preservation.
10mPeptidesIntermediate
Why Retatrutide Preserves Muscle Better Than Tirzepatide
Rapid fat loss typically means muscle loss. But retatrutide's triple action—including glucagon receptor activation—preserves more lean mass than tirzepatide or GLP-1-only compounds. Here's the science.
12mPeptidesIntermediate
Retatrutide vs Tirzepatide: What the Latest Clinical Data Shows
Retatrutide and tirzepatide dominate the peptide conversation, but they're not interchangeable. Here's what the latest clinical research reveals about their differences, efficacy, and mechanisms.
10mPeptidesIntermediate
BPC-157: The Peptide That Heals Joints, Ligaments, and Muscle Faster
BPC-157 is showing remarkable promise in clinical research for rapid tissue regeneration. Learn how this pentapeptide works, what the data shows, and whether it's right for your recovery protocol.
8mPeptidesIntermediate
Retatrutide Phase 3 Results: What the Clinical Data Tells Us
New Phase 3 data shows retatrutide delivering superior metabolic benefits. Here's what researchers found and why it matters.
10mPeptidesIntermediate
Retatrutide Shows 23% Superior Weight Loss vs Tirzepatide in Phase 3 Trial
Retatrutide, the triple-action GLP-1/GIP/glucagon receptor agonist, outperforms tirzepatide by 23% in the latest human clinical trial—the most comprehensive weight loss comparison to date.
10mPeptidesIntermediate
Retatrutide: The Triple-Action Weight Loss Peptide Explained
Retatrutide is a next-generation weight loss peptide targeting three metabolic pathways. Here's how it works and why it outperforms earlier GLP-1 therapies.
10mPeptidesIntermediate
Peptide Research Breakthroughs in 2026: What Clinical Trials Show
2026 marks a pivotal year for peptide research. Here's what the latest clinical data reveals about the most promising peptide candidates and their real-world applications.
12mPeptidesIntermediate
BPC-157: The Tendon Recovery Peptide Backed by Clinical Research
BPC-157 shows promise in clinical research for accelerating tendon repair and recovery. Learn how this peptide works and what the science says about its efficacy.
10mPeptidesIntermediate
MOTS-C: The Peptide That Optimizes Mitochondrial Function
MOTS-C activates mitochondrial function and metabolic pathways linked to longevity and improved physical performance.
12mPeptidesIntermediate
BPC-157: The Complete Guide to the Body's Healing Peptide
BPC-157 is the most versatile healing peptide available. Here's how it works and how to use it effectively.
12mPeptidesIntermediate
GLP-1 Agonists for Metabolic Health: Clinical Evidence & Body Recomposition Strategy
GLP-1 agonists have revolutionized metabolic health. Learn how these peptides work, their effects on metabolism, and how to use them strategically for body composition goals.
18mPeptidesAdvanced
The Ultimate Peptide Tier List for 2026: S-Tier to F-Tier Ranked
From BPC-157 and GLP-1 agonists at the top to overhyped flops at the bottom — here's every major peptide ranked for 2026 across fat loss, skin, longevity, and recovery.
12mPeptidesIntermediate
BPC-157: Complete Guide to Benefits, Dosage, and Research
Explore the healing peptide BPC-157, nicknamed the 'Wolverine peptide' for its remarkable regenerative properties.
10mPeptidesIntermediate
TB-500 (Thymosin Beta-4): Complete Healing & Recovery Guide
Discover how TB-500 promotes tissue repair, reduces inflammation, and supports recovery from injuries.
9mPeptidesIntermediate
Ipamorelin: The Gentle Growth Hormone Secretagogue Guide
Explore why Ipamorelin is considered the gentlest yet effective growth hormone releasing peptide available.
11mPeptidesIntermediate
CJC-1295: DAC vs No DAC - Complete Comparison Guide
Discover the key differences between CJC-1295 with DAC and CJC-1295 without DAC, and which is better for your needs.
9mPeptidesIntermediate
Sermorelin: Natural Growth Hormone Optimization for Anti-Aging
Learn why Sermorelin is a popular choice for natural GH optimization and anti-aging protocols.
11mPeptidesIntermediate
Semaglutide for Weight Loss: Complete Guide to GLP-1 Peptide Therapy
Explore how Semaglutide has revolutionized weight management through GLP-1 receptor agonism.
10mPeptidesIntermediate
Tirzepatide: The Dual Agonist Revolution in Weight Loss
Discover why Tirzepatide's dual mechanism is producing record-breaking weight loss results in clinical trials.
8mPeptidesIntermediate
PT-141 (Bremelanotide): Complete Guide to the Libido Peptide
Discover how PT-141 works through a unique mechanism to enhance sexual desire and function.
12mPeptidesIntermediate
Growth Hormone Peptides for Anti-Aging: The Science Explained
Discover the scientific foundation behind using GH peptides for anti-aging and longevity optimization.
9mPeptidesIntermediate
Melanotan 2: Complete Guide to the Tanning Peptide
Learn about Melanotan 2, the peptide that stimulates melanin production for UV-free tanning effects.
8mPeptidesIntermediate
AOD-9604: The Fat Loss Fragment of Growth Hormone
Discover how AOD-9604 targets fat metabolism specifically, offering a focused approach to body composition.
8mPeptidesIntermediate
Tesamorelin: The FDA-Approved Peptide for Visceral Fat Reduction
Discover Tesamorelin, the only FDA-approved GHRH peptide, specifically indicated for reducing visceral fat.
Also available at /blog for legacy links.